Litigating over royalty payments between two pharmaceutical companies in Switzerland

By Gavin Lunning
Back to News


Gavin Lunning

The firm is instructed to act on behalf of two pharmaceutical companies in relation to a dispute with a global healthcare company in respect to a potential breach of a pharmaceutical licence agreement and a dispute over royalty payments. The case involves a challenge to third party expert determination in respect to the calculation of royalty payments in respect to the licensing of pharmaceutical products.

Latest news

All news